Facebook Instagram Youtube Twitter Tiktok

Stay up to date...

JOIN MY MAILING LIST

QUESTIONS ON NOTICE

Questions are currently being updated, please check back soon for previous questions.

1. When was Australia’s gold sent to London? 2. Did the Bank of England seek permission from Australia to refine Australia’s gold into new bars from 2015 onwards? 3. Does the Reserve Bank of Australia (RBA) discuss Australia’s exchange rate and interest rate settings with other central banks including the Bank of International settlements? If so, what influence do these discussions have on policy settings? 4. If the RBA can subsidise private banks via quantitative easing then why can’t it offer the same facilities to the Federal and State Governments for productive purposes?

17/11/2022

A number of private organisations in the media, medical professionals, and Pfizer have claimed the Pfizer covid vaccine was safe and effective without outlining the risks or lack of quality assurance in regard to testing the vaccine. Genotoxicity, carcinogenic, and longitudinal testing are just some of the tests that didn’t occur. Other risks with missing information are outlined in the table below. There were only around 19,000 from the vaccinated group evaluated when over 21,000 were vaccinated? • What laws are in place to ensure that all risks are outlined as well as the rewards when medical products are advertised or promoted – if laws do exist why weren’t the upheld in the case the Covid-19 vaccine? • What recourse do victims of the Covid-19 vaccine have against private organisations such as the media, pharmaceutical companies, and health professionals who constantly repeated the vaccine is safe and effective without highlighting the risks? • What steps will The Australian Communications and Media Authority take in regard to the promotion of medical products in order to prevent misleading and deceptive conduct in the future? (See table)

17/11/2022

A number of private organisations in the media, medical professionals, and Pfizer have claimed the Comirnaty (Pfizer) COVID-19 vaccine was safe and effective without outlining the risks or lack of quality assurance in regard to testing the vaccine. Genotoxicity, carcinogenic, and longitudinal testing are just some of the tests that didn’t occur. Other risks with missing information are outlined in the table below. There were only around 19,000 from the vaccinated group evaluated when over 21,000 were vaccinated. One of these was Maddie De Garay, a 12-year-old girl, who ended up in a wheelchair being fed through a tube. 1. What laws are in place to ensure that all risks are outlined, as well as the rewards, when medical products are advertised or promoted – if laws do exist why weren’t they upheld in the case the Comirnaty (Pfizer) COVID-19 vaccine? 2. What recourse do victims of the Comirnaty (Pfizer) COVID-19 vaccine have against private organisations such as the media, pharmaceutical companies, and health professionals who constantly repeated the vaccine is safe and effective without highlighting the risks? 3. What steps can the Australian Competition and Consumer Commission take in regard to the promotion of medical products in order to prevent misleading and deceptive conduct in the future? (See table)

16/11/2022

1. Are individuals subjected to Covid vaccine mandates being counted in unemployment figures? If not, how are the number of people out work because of mandates being tracked? 2. Is the Australian Bureau of Statistics (ABS) tracking deaths by vaccinated status – given it is being recorded on the Australian immunisation register it is possible to do? 3. If so, could the ABS please provide a line-by-line breakout of 2021 deaths by vaccinated versus unvaccinated deaths (personal details other than age can be excluded)? Can the detail include date of death and date of last vaccination? 4. Can the ABS provide a breakout of non-specific causes for 2021 deaths by item code? 5. Why isn’t the ABS comparing 2021 data to 2020 data rather than 2015-2019 given those years were pre-Covid conditions?

16/11/2022

1. Senator RENNICK: My question is, again, with regard to the size of the crowd that came to Canberra on 12 February. That area was measured out at 60,000 square metres. You’ve previously said that the crowd size was about 10,000 people, which works out at about one person per every six square metres, which is about two metres by two metres. I was there and can tell you that was not the case. Can I get access to the software where you calculated that? I think last time you said you used some software or you used some method. I’d like to see the methodology you used to calculate the size of that crowd if that’s alright please. Mr Kershaw: I think what we can do is come back to you as to how we made that assessment. 2. Senator RENNICK: I appreciate that. Can I also get access to any correspondence that you had with other government agencies about the size of that crowd?

08/11/2022

Senator RENNICK: Okay, then I’ll ask the professors. There was no genotoxicity study done for the rollout of the vaccine. The vaccine has been rolled out now for up to 18 or 20 months. Has any genotoxicity study been performed on the vaccine given that there are a number of modifications to the spike protein that weren’t in the initial virus? Prof. Murphy: I’ll just see if Ms Duffy from the TGA is online, and whether TGA officials can provide any information about that. They are obviously across all of the material that’s submitted as part of the vaccine evaluation. Ms Duffy: I’m sorry, I don’t have that information, but I’m happy to take it on notice and bring it back on Thursday if that suits you. Senator RENNICK: That’s fine. Initially, when you looked at the assessment it said there were no genotoxicity studies done at all, or carcinogenic or longevity studies. I’m just curious if you’ve done any since? Ms Duffy: We’ll go back and be able to provide that information on Thursday.

08/11/2022

Senator RENNICK: I don’t have those particular New South Wales health numbers in front of me, but vaccinated 1, 2, 3, 4 groups all have higher numbers of hospital transmission and ICU admission. Prof. Kelly: We know, absolutely, without hesitation, that, with fully vaccinated people, just two doses is enough to give at least a 30-times less chance of being hospitalised—in Australia; that’s Australian data. Senator RENNICK: Based on what, because the non-clinical report said – Senator Gallagher: Based on vaccination data. Prof. Kelly: Based on the truth and facts. Senator RENNICK: Be more specific than that. Actually quote the data source, please. Prof. Kelly: That’s the data source from the national data that we have, in the Commonwealth, which is provided to us by the states and territories. Senator RENNICK: Can you provide that to me? I haven’t seen the state data outside New South Wales. Prof. Kelly: I’m very happy to provide that to you on notice.

08/11/2022

43. When filling out an adverse event report there is an option to indicate if the adverse event led to 1) Death 2) A life threating event, 3) admission to hospital, 4) a disability or incapacitation, 5) a congenital anomaly or 6) birth defect or 7) another medically important condition. Can I get the total of these categories to date by age and injury type and the cut-off date at which the numbers are given please?44. In future can the totals of the categories 1) Death 2) A life threating event, 3) admission to hospital, 4) a disability or incapacitation, 5) a congenital anomaly or 6) birth defect or 7) another medically important condition be provided in the weekly reports by age group and event type?

24/02/2022

135. Given the TGA failed to review the gene technology around the Pfizer vaccine did the TGA seek advice and analysis from the Office of Gene Technology Regulator before approving the Pfizer vaccine which involves gene technology? If not why not? 136. Was the TGA required to get authorisation from the Office of the Gene Technology Regulator before approving the Pfizer vaccine? 137. Did the Office of the Gene Technology Regulator provide analysis to the TGA for either of the Astra Zeneca or Pfizer vaccines? If so, could copies please be provided.

24/02/2022

1. When was Australia’s gold sent to London? 2. Did the Bank of England seek permission from Australia to refine Australia’s gold into new bars from 2015 onwards? 3. Does the Reserve Bank of Australia (RBA) discuss Australia’s exchange rate and interest rate settings with other central banks including the Bank of International settlements? If so, what influence do these discussions have on policy settings? 4. If the RBA can subsidise private banks via quantitative easing then why can’t it offer the same facilities to the Federal and State Governments for productive purposes?

17/11/2022

A number of private organisations in the media, medical professionals, and Pfizer have claimed the Pfizer covid vaccine was safe and effective without outlining the risks or lack of quality assurance in regard to testing the vaccine. Genotoxicity, carcinogenic, and longitudinal testing are just some of the tests that didn’t occur. Other risks with missing information are outlined in the table below. There were only around 19,000 from the vaccinated group evaluated when over 21,000 were vaccinated? • What laws are in place to ensure that all risks are outlined as well as the rewards when medical products are advertised or promoted – if laws do exist why weren’t the upheld in the case the Covid-19 vaccine? • What recourse do victims of the Covid-19 vaccine have against private organisations such as the media, pharmaceutical companies, and health professionals who constantly repeated the vaccine is safe and effective without highlighting the risks? • What steps will The Australian Communications and Media Authority take in regard to the promotion of medical products in order to prevent misleading and deceptive conduct in the future? (See table)

17/11/2022

A number of private organisations in the media, medical professionals, and Pfizer have claimed the Comirnaty (Pfizer) COVID-19 vaccine was safe and effective without outlining the risks or lack of quality assurance in regard to testing the vaccine. Genotoxicity, carcinogenic, and longitudinal testing are just some of the tests that didn’t occur. Other risks with missing information are outlined in the table below. There were only around 19,000 from the vaccinated group evaluated when over 21,000 were vaccinated. One of these was Maddie De Garay, a 12-year-old girl, who ended up in a wheelchair being fed through a tube. 1. What laws are in place to ensure that all risks are outlined, as well as the rewards, when medical products are advertised or promoted – if laws do exist why weren’t they upheld in the case the Comirnaty (Pfizer) COVID-19 vaccine? 2. What recourse do victims of the Comirnaty (Pfizer) COVID-19 vaccine have against private organisations such as the media, pharmaceutical companies, and health professionals who constantly repeated the vaccine is safe and effective without highlighting the risks? 3. What steps can the Australian Competition and Consumer Commission take in regard to the promotion of medical products in order to prevent misleading and deceptive conduct in the future? (See table)

16/11/2022

1. Are individuals subjected to Covid vaccine mandates being counted in unemployment figures? If not, how are the number of people out work because of mandates being tracked? 2. Is the Australian Bureau of Statistics (ABS) tracking deaths by vaccinated status – given it is being recorded on the Australian immunisation register it is possible to do? 3. If so, could the ABS please provide a line-by-line breakout of 2021 deaths by vaccinated versus unvaccinated deaths (personal details other than age can be excluded)? Can the detail include date of death and date of last vaccination? 4. Can the ABS provide a breakout of non-specific causes for 2021 deaths by item code? 5. Why isn’t the ABS comparing 2021 data to 2020 data rather than 2015-2019 given those years were pre-Covid conditions?

16/11/2022

1. Senator RENNICK: My question is, again, with regard to the size of the crowd that came to Canberra on 12 February. That area was measured out at 60,000 square metres. You’ve previously said that the crowd size was about 10,000 people, which works out at about one person per every six square metres, which is about two metres by two metres. I was there and can tell you that was not the case. Can I get access to the software where you calculated that? I think last time you said you used some software or you used some method. I’d like to see the methodology you used to calculate the size of that crowd if that’s alright please. Mr Kershaw: I think what we can do is come back to you as to how we made that assessment. 2. Senator RENNICK: I appreciate that. Can I also get access to any correspondence that you had with other government agencies about the size of that crowd?

08/11/2022

Senator RENNICK: Okay, then I’ll ask the professors. There was no genotoxicity study done for the rollout of the vaccine. The vaccine has been rolled out now for up to 18 or 20 months. Has any genotoxicity study been performed on the vaccine given that there are a number of modifications to the spike protein that weren’t in the initial virus? Prof. Murphy: I’ll just see if Ms Duffy from the TGA is online, and whether TGA officials can provide any information about that. They are obviously across all of the material that’s submitted as part of the vaccine evaluation. Ms Duffy: I’m sorry, I don’t have that information, but I’m happy to take it on notice and bring it back on Thursday if that suits you. Senator RENNICK: That’s fine. Initially, when you looked at the assessment it said there were no genotoxicity studies done at all, or carcinogenic or longevity studies. I’m just curious if you’ve done any since? Ms Duffy: We’ll go back and be able to provide that information on Thursday.

08/11/2022

Senator RENNICK: I don’t have those particular New South Wales health numbers in front of me, but vaccinated 1, 2, 3, 4 groups all have higher numbers of hospital transmission and ICU admission. Prof. Kelly: We know, absolutely, without hesitation, that, with fully vaccinated people, just two doses is enough to give at least a 30-times less chance of being hospitalised—in Australia; that’s Australian data. Senator RENNICK: Based on what, because the non-clinical report said – Senator Gallagher: Based on vaccination data. Prof. Kelly: Based on the truth and facts. Senator RENNICK: Be more specific than that. Actually quote the data source, please. Prof. Kelly: That’s the data source from the national data that we have, in the Commonwealth, which is provided to us by the states and territories. Senator RENNICK: Can you provide that to me? I haven’t seen the state data outside New South Wales. Prof. Kelly: I’m very happy to provide that to you on notice.

08/11/2022

43. When filling out an adverse event report there is an option to indicate if the adverse event led to 1) Death 2) A life threating event, 3) admission to hospital, 4) a disability or incapacitation, 5) a congenital anomaly or 6) birth defect or 7) another medically important condition. Can I get the total of these categories to date by age and injury type and the cut-off date at which the numbers are given please?44. In future can the totals of the categories 1) Death 2) A life threating event, 3) admission to hospital, 4) a disability or incapacitation, 5) a congenital anomaly or 6) birth defect or 7) another medically important condition be provided in the weekly reports by age group and event type?

24/02/2022

135. Given the TGA failed to review the gene technology around the Pfizer vaccine did the TGA seek advice and analysis from the Office of Gene Technology Regulator before approving the Pfizer vaccine which involves gene technology? If not why not? 136. Was the TGA required to get authorisation from the Office of the Gene Technology Regulator before approving the Pfizer vaccine? 137. Did the Office of the Gene Technology Regulator provide analysis to the TGA for either of the Astra Zeneca or Pfizer vaccines? If so, could copies please be provided.

24/02/2022

HAVE YOUR SAY...

THE ISSUES

Click on an interest area to read articles and learn more about the work I am doing in Parliament.

Taxation, Finance & Economy

READ MORE

Education & Family

READ MORE

Energy

READ MORE

Environment

READ MORE

Health, Aged Care & Seniors

READ MORE

Primary Industries

READ MORE

Immigration & Foreign Affairs

READ MORE

Infrastructure, Manufacturing, Transport & Tourism

READ MORE

Defence

READ MORE

Federation Reform

READ MORE

DON'T BE SILENT. HAVE YOUR SAY!

I’m working on a range of issues currently in the Senate however I need your support so that my other Parliamentary colleagues know that these are issues that you feel strongly about.
Remember that we are stronger in numbers!

Visit People First Party
Facebook Instagram Youtube Twitter Tiktok

GET MY Newsletter

I may get kicked off social media soon for speaking too much truth so please join my mailing list so we can always stay in touch...

Thank you,

Gerard

COMPLETE MY 30 SECOND SURVEY